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Abstract
The peripheral changes in the uninvolved skin adjacent to the extending psoriatic lesions may represent early 
events. The sequence of these events remains controversial. In the present study we evaluated epidermal and dermal 
aspects of the margin of the progressive psoriatic plaque, the distant uninvolved skin and normal healthy skin, using 
immunohistochemistry with markers for keratinization, proliferation and connective tissue: filaggrin, involucrin, 
Ki-67 and tenascin. The results showed that: (i) processes in distant uninvolved skin were comparable with the 
observations in normal skin; (ii) in the margin zone of the spreading psoriatic lesion, following the increased 
appearance of tenascin, the transition into parakeratosis, abnormal expression of filaggrin, involucrin and recruitment 
of cycling epidermal cells, happened simultaneously. The simultaneous normalization of these epidermal processes 
might be a consequence of a signal which is simultaneously transduced to the basal and suprabasal cell layers of the 
epidermis. Based on the present results and earlier findings, we would like to propose a triple stage model for the 
development of the psoriatic lesion: Stage 1, involvement of the stroma; stage II, inflammatory infiltrate formation 
and penetration into the upper layers of the epidermis, with suprabasal expression of keratin 16; stage III, recruitment 
of cycling epidermal cells and abnormal terminal differentiation. Further studies are required on the regulation of 
tenascin expression, focusing on factors derived from the stroma affecting both recruitment of cycling epidermal cells, 
involucrin and filaggrin expression. An intermediate step in the dermo-epithelial interrelation is the inflammatory 
infiltrate, penetrating into the most superficial zone of the epidermis, and the suprabasal expression of keratin 16. 
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1. Introduction
Initial changes in psoriasis differ from those in 
the fully developed psoriatic plaque.
At the cellular level, the established psoriatic 
lesion is characterized by epidermal changes con­
sisting of an increased proliferation and incom­
plete keratinization, and dermal changes such as 
inflammation and an increased expression of the 
extracellular matrix glycoprotein tenascin. In con­
trast to the histological changes found in the 
mature psoriatic plaque, the pin-point papules 
show only slight epidermal proliferation, whereas 
the changes in the corium, consisting of inflamma­
tory infiltrates, are more pronounced [1-14]. The 
sequence of events however remains controversial. 
An experimental approach to this problem is the 
investigation of the margin of the spreading psori­
atic lesion [15-18], In this experimental model, 
van de Kerkhof et al. reported that changes in the 
capillary may precede those in the epidermis dur­
ing the centrifugal expansion of the psoriatic le­
sions [15]. Using laser-Doppler flowmetry and 
immimocytochemical techniques, Hull et al. pos­
tulated that the earliest change in the developing 
psoriatic plaque is an increased blood flow, possi­
bly associated with a diffusible humoral initiating 
factor that accumulates at the active edge, stimu­
lating transformation of normal skin to psoriatic 
plaques [16], De Mare et al. reported that the 
suprabasal K s8.12 binding (keratin 16 expression) 
was the earliest change in the epidermis [17]. De 
Jong et al. found evidence that the dermal com­
partment is involved early in the pathogenesis of 
psoriasis [18].
In the present study, we compared and con­
trasted the immunohistological findings in the 
normal human adult skin of healthy volunteers, 
the uninvolved skin of psoriatic patients and the 
margin of spreading psoriatic lesions.
In the epidermis, parameters for keratinization 
and proliferation were studied. Keratinization was 
characterized using markers for filaggrin and in- 
volucrin. Filaggrin and involucrin are important 
proteins in the process of differentiation [19-24]. 
The monoclonal antibody Ki-67 was used as a 
proliferation marker. Ki-67 recognizes a nuclear 
antigen present in cycling epidermal cells [25-28].
In the dermis we studied the expression of the 
extracellular matrix glycoprotein tenascin
[14,29,30],
2. Material and methods
2.1. Patients
Fifteen patients (eight male and seven female; 
mean age 49.4 (28-69 years)) suffering from 
plaque psoriasis participated in this study. They 
did not receive any topical treatment for at least 2 
weeks and no systemic treatment for at least 1 
month. In all patients the total body extent varied 
between 5-10%. In 10 patients suffering from 
unstable progressive plaque psoriasis, 6-mm 
punch biopsies were taken across the margin of a 
spreading lesion. In five of these patients a 3-mm 
punch biopsy was also taken from the uninvolved 
skin at exactly 10 cm from the psoriatic lesions. In 
the other five psoriatic patients with stable disease 
we only took 3-mm punch biopsies from the 
uninvolved skin, also at exactly 10 cm from a 
psoriatic lesion.
From eight healthy volunteers (three female 
and five male; mean age 26.1 (23-33 years)) 3-mm 
punch biopsies were taken.
All biopsies of the uninvolved skin of psoriatic 
patients and normal human adult skin of the 
healthy volunteers were take from the skin of the 
upper arm.
2.2, Monoclonal antibodies
To approximate the number of cycling cells we 
used the monoclonal anybody Ki-67, which recog­
nizes a nuclear antigen present in cycling cells 
(1:10, Ki-67, Dakopatts, Copenhagen, Denmark) 
[25-28]. To assess epidermal differentiation a 
monoclonal antibody against filaggrin (1:500, an- 
tifilaggrin, BTI, BT576) [31] and a monoclonal 
antibody against involucrin (M on-150, 1:25) [32] 
were used.
A monoclonal antibody against tenascin 
(T2H5, 1:2000) was obtained from AA 
Verstraeten, The Netherlands Cancer Institute, 
Amsterdam, The Netherlands.
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Table 1
Histological results from the normal healthy and from the distant uninvolved skin of psoriatic patients (mean ±  SEM) and the 
p -values
Healthy skin (n = 8) Uninvolved skin (/■/= 10) p -value
Filaggrin str. corneum (%) 100 ± 0 100 ± 0 1.00
Filaggrin str. granulosum (%) 100 ± 0 100 ± 0 1.00
Ki-67 positive nuclei 10.5 ±2.5 9.2 ±  2,6 0.69
Involucrin interpapillar (%) 20.9 ±  2.7 17.4 ±  1.6 0.75
involucrin tip (%) 25.4 ±  1.2 26.1 ±  1.3 0.23
Tenascin 1.3 ±0 .2 1.2 ±  0.1 0.78
23, Staining procedure
Every biopsy was embedded in Tissue Tek OCT 
Compound (Miles Scientific, Naperville, USA), 
snap-frozen in liquid nitrogen and stored at — 80° 
until use. From each biopsy consecutive sections 
were cut (6 fj.ni), airdried and fixed in acetone/ 
ether (60:40%) in case of Ki-67 staining and in 
acetone for the staining with the other mono­
clonal antibodies. An indirect immunoperoxidase 
technique was used. For 10 minutes the slides 
were fixed in acetone/ether (60:40 vol%) (Ki-67/ 
filaggrin staining) or acetone (involucrin and 
tenascin). After these slides were air-dried they 
were put in a phosphate-buffered stock solution
(PBS solution: 360 ml Na2H P 0 4 (7.9 g Na2H P 04, 
Merck in 500 ml demineralized water) plus 70 ml 
NaH2P 0 4 (13.8 g N aH 2P 0 4, Merck, in 500 ml
demineralized water) plus 70 ml demineralized 
water. For 60 min, the slides were incubated with 
the monoclonal antibodies. After washing in 
phosphate buffer, the slides were incubated with 
rabbit anti-mouse immunoglobulin conjugated 
with peroxidase (1:50, RAMPO). After washing in 
the phosphate-buffered stock solution and pre-in­
cubation with sodium-acetate buffer (pH 4.9), a 
solution of 3 amino-9-ethylcarbazoIe (AEC) in 
sodium-acetate buffer containing 0,01% H 20 2 was 
added for 10 min.
All slides were counterstained with M ayer’s 
Haematoxylin (Sigma, St. Louis, MO) and 
mounted in glycerol gelatin.
2.4. Histological examination
Epidermal proliferation was measured by 
counting the number o f Ki-67 positive nuclei per 
mm length of the section. In exactly the same area
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Fig. 1. Filaggrin and Ki-67 expression in the distant unin­
volved skin of a psoriatic patient. The filaggrin expression 
shows a continuous staining pattern in the stratum granulo- 
sum and stratum corneum. A minimal expression of nuclear 
Ki-67 is- seen in the basal layer.
Fig. 2. Involucrin expression in the normal healthy skin. A 
continuous staining pattern in the upper epidermis can be
seen.
182 M.J.P. Gerritsen et al. ( Journal o f Dermatológica! Science 14 (1997) 179-188
■ r  •
Fig. 3. Tenascin expression in the normal healthy skin. The 
tenascin expression is discontinuously distributed adjacent to 
the basal lamina.
the filaggrin expression was assessed by measuring 
the percentage of the length of the stratum 
corneum and stratum granulosum which was 
stained [34].
The involucrin expression was assessed by cal­
culating the ratio positive cell layers/total cell 
layers o f the living epidermis. This was done on 
two sites: at the tip of a dermal papil and between 
two dermal papillae [34].
The distribution of tenascin in the papillary 
dermis was assessed using the following grading 
system:
(1) Continuous expression adjacent to the basal 
lamina (C) versus discontinuous expression 
adjacent to the basal lamina (D);
(2) Staining intensity (0-3) [35].
The immunohistochemical findings in the biop­
sies taken from the margin of an active psoriatic 
lesion were compared with the localization of 
parakeratosis to assess the transition point into 
uninvolved skin. The orientation of these biopsies 
was from their clinically involved edge to their 
symptomless edge. These biopsies were examined 
on four spots: on 20% and 40% (involved part), 
60% and 80% (uninvolved part) of the length of 
the sections.
2,5. Statistical evaluation
We used the M ann-W hitney test for statistical 
analysis o f the results from the biopsies of the
distant uninvolved skin of psoriatic patients and 
from the normal human adult skin. For statistical 
analysis of the results from the biopsies o f the 
margin zone, we used the Wilcoxon test for 
matched pairs.
3. Results
3 A. Normal healthy adult skin and distant 
tin involved skin o f psoriatic patients
We did not observe a statistically significant 
difference between the results from the normal 
skin of healthy volunteers and the uninvolved skin 
of the psoriatic patients (Table 1). The filaggrin 
expression in the stratum granulosum and its 
expression in the stratum corneum was 100 ±  0% 
(/>= 1.00) in the normal healthy skin as in the 
uninvolved skin (Fig. 1). The involucrin expres­
sion at the interpapillar region and above the tip 
of a dermal papilla in the uninvolved skin and in 
the healthy skin were within the same range (/;inlcr. 
papiliar >0.75 and /?tip>0.2) (Fig. 2). Seven of 
eight biopsies of normal skin showed a discontin­
uous tenascin expression immediately beneath the 
basal lamina, compared to eight of 10 biopsies of 
uninvolved skin. The staining intensity of the 
tenascin expression in the normal healthy skin 
and the uninvolved skin did not show a significant 
difference (/;>  0.78) (Fig. 3).
3.2. Margin o f spreading psoriatic plaques
In eight out of 10 biopsies taken from the 
margin of a spreading psoriatic lesion, the transi­
tion of the parakeratotic horny layer into an 
orthokeratotic stratum corneum was abrupt. In 
the involved areas of these biopsies a marked 
acanthosis was observed, whereas in the unin­
volved parts the acanthosis disappeared. In the
remaining two biopsies we did not observe parak­
eratosis. In one of these biopsies however, we 
observed acanthosis.
The histological examination in the biopsies of 
the margin zone was performed at 20%, 40%, 60% 
and 80% of the length of the sections (Tables 
2-5), 20 and 40% representing the involved part
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Tabic 2
The histological results from the 20% zone of the margin of spreading psoriatic plaques (the involved part). Numbers 1-10 represent 
the 10 biopsies taken from the margin of a spreading psoriatic lesion
1 2 3 4 5 6 7 8 9 10
Filagg. str. corneum (%) 0 0 0 100 80 20 0 0 0 20
Filagg,, str. gran. (%) 40 30 100 100 100 10 50 100 50 80
Ki-67 positive nuclei 84 84 184 16 80 92 304 72 248 156
Involucrin interpap. (%) 36 60 nd 33 27 28 47 nd 28 38
Involucrin tip (%) 72 50 nd 56 40 42 70 nd 56 64
Tenascin C/3 C/3 C/2 C/3 C/3 C/3 C/3 C/2 C/3 nd
nd, not done; C, continuous expression.
and 60 and 80% representing the uninvolved area
of the biopsy.
At 20% of the sections the filaggrin expression 
in the stratum corneum and stratum granulosum 
was discontinuous or absent. Compared to the 
uninvolved part of the margin zone at 80%, filag­
grin expression was significantly different
(Pcorneam ^  0 .0 1 ,  />gnimilosum <  0 . 0 2 )  and comparable
with the filaggrin staining as can be observed in 
normal healthy skin.
The number of Ki-67 positive nuclei in the 
involved areas of the sections (areas with evident 
parakeratosis) was markedly elevated and differ­
ent from the number we found in the uninvolved 
part of the sections [p < 0.005). In the two sec­
tions without parakeratosis the number of Ki-67 
positive nuclei did show a minor increase. Fig. 4 
demonstrates the Ki-67/filaggrin staining in the 
40-60% zone.
In the involved parts (at 20 and 40%) the 
involucrin expression was seen in more layers of 
the stratum spinosum, whereas the expression in 
the uninvolved areas was observed exclusively in 
the granular layer and the upper part of the 
stratum spinosum. The difference between the 
involucrin expression at 20%) and the expression 
at 80% of the length of the section was significant
(/Wr,K,pillar s  0-04; />,ip<0.01). Fig. 5 demon-
strates the involucrin expression in the 40-60% 
zone.
In eight biopsies, a pronounced parakeratosis 
was observed in the involved areas. A transition 
point between ortho- and parakeratosis was seen 
at about 40-60% of the length of the sections. 
These biopsies also showed a transition point for
filaggrin and involucrin expression from involved 
to normal pattern at 40-60%.
Tenascin is an extracellular matrix glyco­
protein. In vitro studies suggest that proliferating 
epithelium induces the production of tenascin by 
mesenchymal cells [33]. In the involved areas, 
tenascin expression was observed as a continuous 
and intense staining pattern in the dermis immedi­
ately adjacent to the basal lamina. Com pared to 
the tenascin expression in the normal healthy 
skin, its staining in the involved areas extended to 
the upper dermis (Fig, 6). In six out o f nine 
sections we also observed a continuous but a 
substantially less pronounced staining pattern in 
the uninvolved parts, The other three sections 
showed a transition into a more discontinuous 
pattern in the uninvolved areas. The intensity of 
the anti-tenascin staining in the involved skin and 
its intensity in the uninvolved areas did not show 
a statistically significant difference (/; =  0.67), 
while the staining intensities o f the uninvolved 
areas in the margin zone did show a substantial 
difference with the expression observed in the 
normal healthy skin and the uninvolved skin at 10 
cm distance from a lesion (p = 0.02 and p = 0.005, 
respectively).
4. Discussion
Margins of spreading psoriatic lesions permit 
the investigation of the sequence of events during 
the development of psoriasis. The peripheral 
changes in the uninvolved skin adjacent to the 
extending lesions may represent early changes. In
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Table 3
The histological results from the 40% zone of the margin of spreading psoriatic plaques (the involved part). Numbers 1-10 represent 
the 10 biopsies taken from the margin of a spreading psoriatic lesion
nd, not done; C, continuous expression.
1 2 3 4 5 6 7 8 9 10
Filagg. str. corneum (%) 0 60 0 100 80 20 0 0 0 20
Filagg. str. gran. (%) 50 40 100 100 100 100 80 100 100 100
Ki-67 positive nuclei 40 52 204 16 60 28 96 48 120 140
Involucrin interpap, (%) 32 30 nd 29 32 48 53 nd 36 32
Involucrin tip (%) 60 30 nd 56 53 70 62 nd 33 83
Tenascin C/3 C/3 C/2 C/3 C/3 C/3 C/2 C/2 C/3 n d
the present study we confirm that changes in 
dermal expression of tenascin precede epidermal 
changes. Tenascin was the only parameter which 
did not show a statistically significant difference 
between the involved and the uninvolved areas of 
the margins o f progressive psoriatic lesions. These 
findings confirm the observations of de Jong et al. 
[18]. In the uninvolved skin at 10 cm distance 
from a psoriatic lesion, the tenascin expression 
was within the same range as the staining pattern 
we observed in the normal healthy skin, whereas 
the staining intensity of tenascin in the uninvolved 
part o f the margins (at 80%) was statistically 
significantly different from the expression we ob­
served in the normal healthy skin and the distant 
uninvolved skin.
In the epidermis the transition point between 
parakeratosis and orthokeratosis was observed 
between 40 and 60% of the length of the section. 
In the same region we observed a transition point 
with regard to the number of Ki-67 positive nu­
clei, filaggrin and involucrin expression from an 
involved into a noil-involved pattern. These 
parameters were expressed differently in the in­
volved and in the uninvolved parts of the margin 
zone. In the uninvolved parts the number of Ki-67 
positive nuclei, the filaggrin and involucrin ex­
pression were not significantly different from the 
values which we observed in the normal healthy 
and in the distant uninvolved skin.
The early expression of tenascin in the dermal 
compartment o f the uninvolved skin adjacent to 
the spreading psoriatic lesion together with the 
normal staining pattern of Ki-67, filaggrin and 
involucrin in the uninvolved areas of the marginal
zone suggest that the dermis is involved in an 
early stage of the evolution of psoriasis. Several 
observations suggest that activated epithelium, 
wound healing and hyperproliferative skin dis­
eases (cancer, psoriasis) induce tenascin expres­
sion in the human dermis. Mackie et al. suggested 
that the migrating, proliferating epidermis induces 
the expression of tenascin [33]. The present results 
suggest that tenascin expression is an earlier event 
than the recruitment of cycling cells.
The present investigation reveals that the ex­
pression of the epidermal proteins filaggrin and 
involucrin in psoriatic epidermis differs from their 
expression in the uninvolved parts (60 and 80%), 
in the normal healthy skin and in the uninvolved 
skin at 10 cm distance from a psoriatic lesion. 
These observations indicate that an abnormal ker- 
atinization process is secondary to other changes. 
The fact that the transition points between unin­
volved and involved psoriatic skin, with respect to 
parakeratosis, recruitment of cycling epidermal 
cells, filaggrin and involucrin expression between 
uninvolved and involved psoriatic skin were ob­
served between 40 and 60%o of the length of the 
section strongly suggest a close relationship be­
tween epidermal hyperproliferation and abnormal 
keratinization. Our observations confirm the re­
sults of van de Kerkhof et al. [15]. They observed 
a simultaneous change of enzyme markers for 
proliferation and keratinization in the margin 
zone of a spreading psoriatic lesion. The simulta­
neous normalization of these epidermal processes 
might be a consequence of a signal which is 
simultaneously transduced to the basal and supra- 
basal cell layers of the epidermis.
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Table 4
The histological results from the 60% zone of the margin of spreading psoriatic plaques (the uninvolved part). Numbers 1-10 
represent the 10 biopsies taken from the margin of a spreading psoriatic lesion
1 2 3 4 5 6 7 8 9 10
Filagg. str. corneum (%) 100 100 60 100 50 100 100 100 100 100
Filagg. str, gran. (%) 100 100 100 100 100 100 100 100 100 100
iCi-67 positive nuclei 16 12 128 16 44 8 32 40 40 12
involucrin interpap. (%) 26 18 nd 38 29 21 22 nd 37 29
Involucrin tip (%) 63 25 nd 56 47 33 38 nd 50 83
Tenascin C/2 D/1 C/2 C/3 C/3 C/2 D/2 C/2 C/3 nd
nd, not done; C, continuous expression; D, discontinuous expression.
Based on the present results and earlier findings 
[18], we would like to propose a triple stage model 
for the development of the psoriatic lesion: Stage 
I, involvement of the stroma; stage II, inflamma­
tory infiltrate formation, penetration into the up­
per layers of the epidermis, with suprabasal 
expression of keratin 16; stage III, recruitment of 
cycling epidermal cells and abnormal terminal 
differentiation.
The changes of the stroma in Stage I could well 
be the result of mediators, diffusing from the 
psoriatic lesion into the clinically uninvolved skin. 
Possible candidates include: TGF/i, a mediator 
which is capable of inducing tenascin; [36] and 
arachidonic acid derivatives which have a potent 
effect on endothelial cells. A remarkable feature, 
however, is the relatively large interval between 
stage I and stage II (the infiltrate formation and 
keratin 16 expression). Some degree of tachyphy­
laxis to respond to mediators of inflammation 
might be of relevance in this respect. A reduced 
responsiveness of the clinically uninvolved psori­
atic skin to epicutaneous application of the ei- 
cosanoid leukotriene B4 has been demonstrated in 
previous experiments [37,38]. Such a defense sys­
tem against pro-inflammatory events could be 
interpreted as an attempt of the skin to keep 
psoriatic plaques restricted to sharply demarcated 
plaques. It is attractive to speculate that this 
process prevents overt inflammatory events in the 
symptomless skin and during stage I of the inter­
phase,
Stage II represents the expression of keratin 16 
in the suprabasal compartment and the appear­
ance of the inflammatory infiltrate. In a previous
experiment, an association between keratin 16 
expression and cutaneous inflammation was 
shown [18]. Following tape stripping of the nor­
mal human skin, keratin 16 expression had al­
ready appeared after 24 h, well before overt 
epidermal hyperproliferation, whilst the inflam­
matory infiltrate was present 24 h post-stripping. 
Several other observations further strengthen the 
supposition that the expression of keratin 16 is 
not the result of epidermal proliferation but 
rather might be independent from proliferation of 
the epidermis. In lupus erythematodes, a skin 
disorder characterized by atrophy of the skin, the 
expression of keratin 16 is prominent above the 
inflamed skin [39]. In monogenic disorders of 
keratinization, the expression of keratin 16 ap­
peared to be associated with the inflammatory 
conditions, but to our surprise did not always 
occur in hyperproliferative diseases [40]. There­
fore, not only in psoriasis but in many skin condi­
tions keratin 16 expression should be regarded as 
part of an inflammatory response. Controversy 
remains with respect to the question which inflam­
matory cell can be identified as 7e premier\  Ac­
cording to some authors the polymorphonuclear 
leukocyte is the first invader, according to others 
the mast cell, the monocyte, or the T lymphocyte 
[3,12,18,41]. So far, the communis opinio is that 
there is no single cell type involved as the ‘on- 
switcher’ of psoriatic inflammation.
Stage III comprises a process of recruitment of 
cycling epidermal cells and a change in the cell 
layers containing involucrin and filaggrin. Al­
though the molecular regulation of these changes 
is by no means totally understood, the observa­
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Tabic 5
The histological results from the 80% zone of the margin of spreading psoriatic plaques (the uninvolved part). Numbers 1 —10 
represent the 10 biopsies taken from the margin of a spreading psoriatic lesion
1 2 3 4 5 6 7 8 9 10
Filagg. str. comeum {V») 100 100 60 100 100 100 100 100 100 100
Filagg. str. gran. (%) 100 100 100 100 100 100 100 100 100 100
Ki-67 positive nuclei 20 8 156 8 28 0 20 12 12 8
Involucrin interpap. (%) 15 11 nd 42 23 14 44 nd 25 23
Involucrin tip (%) 40 11 nd 50 41 22 44 nd 43 44
Tenascin C/2 D/1 C/2 C/3 C/3 D/2 D/2 C/2 C/3 nd
nd, not done; C, continuous expression; D, discontinuous expression.
tion of a simultaneous transition of these pro­
cesses is most likely caused by a common reg­
ulating process. It has been shown, in vitro, 
that activation of the EGF receptor and an en­
hanced transcription of TGFoc can be induced 
by TN Fa, IL8 and y-interferone [42]. Activa­
tion of the EG F receptor and increased tran­
scription of T G Fa is associated with activation 
of phospholipase C, yielding an increased intra- 
cellular Ca^ + concentration, and activation of 
protein kinase C. An increased intracellular
concentration of calcium leads to activation of 
transglutaminase. Phosphorylation of the 
sodium hydrogen antiport by protein kinases 
will elicit the recruitment process of cycling 
epidermal cells. It has been shown that activa­
tion of protein kinase C will induce keratiniza- 
tion [43]. Therefore the induction of epidermal 
growth and altered keratinization following the 
infiltrate formation can be controlled by joint 
molecular pathways. However, further investi­
gations are required to identify the exact mech­
anisms involved.
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Fig. 4. Filaggvin and Ki-67 expression in the 40-60% zone of 
the margin of a spreading psoriatic lesion. The 40% zone (left, 
the involved part of the biopsy) shows a markedly decreased 
filaggrin expression in the granular layer and stratum corneum 
and an increased number of Ki-67 positive nuclei in the lower 
region of the epidermis. In the 60% zone (right, the uninvolved 
part of the biopsy) a normal filaggrin expression can be seen, 
while the number of Ki-67 positive nuclei has markedly de­
creased, compared with the 40% zone.
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Fig. 5. Involucrin expression in the 40-60% zone of the 
margin of a spreading psoriatic lesion. On the right (40% zone, 
involved part) the involucrin expression is extended to the 
lower part of the epidermis, whereas in the 60% zone (left, the 
uninvolved part) the involucrin expression is seen in less ccll 
layers of the epidermis.
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Fig. 6, Tenascin expression in the 40-60% zone of the margin 
of a spreading psoriatic lesion. On the right (40% zone, 
involved part) the tenascin expression is extended to the upper 
dermis, whereas in the 60% zone (left) the tenascin expression 
shows an intense and continuous distribution adjacent to the 
basal lamina.
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